Stonepine Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-839,514	Closed	-$2.56M	–	22
2023 Q4	$2.56M	Sell	839,514 -880,486	-51%	-$2.69M	1.11%	12
2023 Q3	$5.16M	Buy	1,720,000 +967,912	+129%	+$2.9M	1.71%	14
2023 Q2	$2.81M	Buy	752,088 +67,580	+10%	+$253K	1.01%	18
2023 Q1	$2.29M	Buy	+684,508	New	+$2.29M	0.77%	19